Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety, tolerability, PK, and PD of GSK3389404 in chronic hepatitis B has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GSK3389404 (GSK3389404)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2020-01-22